Search result
Interview with Prof. Dr. Anastasia Khvorova – Winner of the Else Kröner Fresenius Prize for Medical Research 2025
The Else Kröner Fresenius Foundation is awarding the Else Kröner Fresenius Prize for Medical Research in recognition of Khvorova's pioneering work in the field of RNA-based therapies.
Presseeinladung für Kultur und Geschichte: Festveranstaltung zum 100. Geburtstag von Else Kröner mit der Verleihung des Else Kröner Fresenius Preises für Medizinische Forschung 2025
Einladung ausschließlich für Pressevertreter (nur mit Anmeldung)
Invitation to the press - Announcement of the 2025 research prize winner: The 2025 Else Kröner Fresenius Prize for Medical Research goes to RNA therapeutics for treating Huntington's disease
Invitation for press representatives only (registration required): Join Fresenius SE & Co. KGaA in celebrating the 100th birthday of Else Kröner
Defining Cell States Underlying Therapeutic Resistance in Myeloma
Institution: Institute of Clinical Chemistry and Pathobiochemistry, TUM University Hospital/ TranslaTUM
Applicant: Julia Frede, PhD
Development and evaluation of a multiparameter neurofilament biomarker panel for neurological diseases
Institution: University Hospital Ulm, Neurology
Applicant: Steffen Halbgebauer
Illuminating the Blind Spot: Advancing the Understanding and Explanation of Functional Cognitive Disorder
Institution: Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum
Applicant: Dr. Johannes Jungilligens
Prize Ceremony: Else Kröner Fresenius Prize for Medical Research 2025
On May 15, 2025, the Else Kröner Fresenius Prize for Medical Research 2025 will be awarded in the Städel Museum in Frankfurt am Main.
Exploiting transcriptional heterogeneity in pancreatic cancer: precision medicine through KRASG12D inhibitor-based therapies
Institution: Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital
Applicant: Bo Kong
Metabolic control of cellular plasticity in prostate cancer: mechanisms and therapeutic opportunities
Institution: Institute for Diabetes and Cancer, Helmholtz Munich
Applicant: Mohamed Abouelmaaty
Investigating autoimmune pathogenicity of single nucleotide polymorphism -linked truncated variants of TSH-receptor gene in Graves’ disease: an approach to applying genetics to personalized medicine
Institution: Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, Universitätsklinikum Essen
Applicant: PD Dr. Anke Daser